{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T14:08:31Z","timestamp":1794406111166,"version":"4.9.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T00:00:00Z","timestamp":1562889600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T00:00:00Z","timestamp":1562889600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003990","name":"Conseil R\u00e9gional, \u00cele-de-France","doi-asserted-by":"publisher","award":["PhD"],"award-info":[{"award-number":["PhD"]}],"id":[{"id":"10.13039\/501100003990","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13023-019-1141-2","type":"journal-article","created":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T13:02:37Z","timestamp":1562936557000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Adherence\u00a0with metreleptin therapy and health self-perception in patients with lipodystrophic syndromes"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8342-1596","authenticated-orcid":false,"given":"Camille","family":"Vatier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Kalbasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christine","family":"Vantyghem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lascols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"J\u00e9ru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Daguenel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Gautier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Buyse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Vigouroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,12]]},"reference":[{"issue":"12","key":"1141_CR1","doi-asserted-by":"publisher","first-page":"4500","DOI":"10.1210\/jc.2016-2466","volume":"101","author":"RJ Brown","year":"2016","unstructured":"Brown RJ, Araujo-Vilar D, Cheung PT, Dunger D, Garg A, Jack M, et al. The diagnosis and Management of Lipodystrophy Syndromes: a multi-society practice guideline. J Clin Endocrinol Metab. 2016;101(12):4500\u201311.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1141_CR2","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2165\/00002018-200124030-00001","volume":"24","author":"E Martinez","year":"2001","unstructured":"Martinez E, Garcia-Viejo MA, Blanch L, Gatell JM. Lipodystrophy syndrome in patients with HIV infection: quality of life issues. Drug Saf. 2001;24(3):157\u201366.","journal-title":"Drug Saf"},{"issue":"4","key":"1141_CR3","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1097\/00126334-200212010-00006","volume":"31","author":"J Blanch","year":"2002","unstructured":"Blanch J, Rousaud A, Martinez E, De Lazzari E, Peri JM, Milinkovic A, et al. Impact of lipodystrophy on the quality of life of HIV-1-infected patients. J Acquir Immune Defic Syndr. 2002;31(4):404\u20137.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"1141_CR4","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1097\/00002030-200104130-00025","volume":"15","author":"NH Dukers","year":"2001","unstructured":"Dukers NH, Stolte IG, Albrecht N, Coutinho RA, de Wit JB. The impact of experiencing lipodystrophy on the sexual behaviour and well-being among HIV-infected homosexual men. AIDS. 2001;15(6):812\u20133.","journal-title":"AIDS."},{"issue":"4","key":"1141_CR5","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s11136-004-2580-2","volume":"14","author":"R Burgoyne","year":"2005","unstructured":"Burgoyne R, Collins E, Wagner C, Abbey S, Halman M, Nur M, et al. The relationship between lipodystrophy-associated body changes and measures of quality of life and mental health for HIV-positive adults. Qual Life Res. 2005;14(4):981\u201390.","journal-title":"Qual Life Res"},{"issue":"3","key":"1141_CR6","first-page":"152","volume":"10","author":"G Guaraldi","year":"2008","unstructured":"Guaraldi G, Murri R, Orlando G, Squillace N, Stentarelli C, Zona S, et al. Lipodystrophy and quality of life of HIV-infected persons. AIDS Rev. 2008;10(3):152\u201361.","journal-title":"AIDS Rev"},{"issue":"1","key":"1141_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/qjmed\/90.1.27","volume":"90","author":"SN Jackson","year":"1997","unstructured":"Jackson SN, Howlett TA, McNally PG, O'Rahilly S, Trembath RC. Dunnigan-Kobberling syndrome: an autosomal dominant form of partial lipodystrophy. QJM. 1997;90(1):27\u201336.","journal-title":"QJM."},{"key":"1141_CR8","doi-asserted-by":"publisher","first-page":"123","DOI":"10.4137\/CCRep.S40196","volume":"9","author":"C Musso","year":"2016","unstructured":"Musso C, Major ML, Andres E, Simha V. Metreleptin treatment in three patients with generalized lipodystrophy. Clin Med Insights Case Rep. 2016;9:123\u20137.","journal-title":"Clin Med Insights Case Rep"},{"issue":"3","key":"1141_CR9","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s10880-012-9337-9","volume":"20","author":"T Baines","year":"2013","unstructured":"Baines T, Wittkowski A. A systematic review of the literature exploring illness perceptions in mental health utilising the self-regulation model. J Clin Psychol Med Settings. 2013;20(3):263\u201374.","journal-title":"J Clin Psychol Med Settings"},{"issue":"2","key":"1141_CR10","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/s12020-017-1437-8","volume":"58","author":"K Miehle","year":"2017","unstructured":"Miehle K, Stumvoll M, Fasshauer M, Hierl T. Facial soft tissue volume decreases during metreleptin treatment in patients with partial and generalized lipodystrophy. Endocrine. 2017;58(2):262\u20136.","journal-title":"Endocrine."},{"issue":"1","key":"1141_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/pon.3591","volume":"24","author":"P Hopman","year":"2015","unstructured":"Hopman P, Rijken M. Illness perceptions of cancer patients: relationships with illness characteristics and coping. Psychooncology. 2015;24(1):11\u20138.","journal-title":"Psychooncology."},{"issue":"3","key":"1141_CR12","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jpsychores.2013.05.003","volume":"75","author":"R Foxwell","year":"2013","unstructured":"Foxwell R, Morley C, Frizelle D. Illness perceptions, mood and quality of life: a systematic review of coronary heart disease patients. J Psychosom Res. 2013;75(3):211\u201322.","journal-title":"J Psychosom Res"},{"issue":"2","key":"1141_CR13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0022-3999(00)00204-X","volume":"50","author":"R Edwards","year":"2001","unstructured":"Edwards R, Suresh R, Lynch S, Clarkson P, Stanley P. Illness perceptions and mood in chronic fatigue syndrome. J Psychosom Res. 2001;50(2):65\u20138.","journal-title":"J Psychosom Res"},{"issue":"1","key":"1141_CR14","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/eat.20056","volume":"37","author":"J Holliday","year":"2005","unstructured":"Holliday J, Wall E, Treasure J, Weinman J. Perceptions of illness in individuals with anorexia nervosa: a comparison with lay men and women. Int J Eat Disord. 2005;37(1):50\u20136.","journal-title":"Int J Eat Disord"},{"issue":"11","key":"1141_CR15","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1111\/j.1464-5491.2011.03298.x","volume":"28","author":"J Mc Sharry","year":"2011","unstructured":"Mc Sharry J, Moss-Morris R, Kendrick T. Illness perceptions and glycaemic control in diabetes: a systematic review with meta-analysis. Diabet Med. 2011;28(11):1300\u201310.","journal-title":"Diabet Med"},{"issue":"6","key":"1141_CR16","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.pcd.2015.03.001","volume":"9","author":"A Voigt","year":"2015","unstructured":"Voigt A, Madrid E, Pacheco-Huergo V, Rastello A, Castro D, Navarro-Brito I, et al. Association of glycaemia with perceived threat of illness in patients with type 2 diabetes. Prim Care Diabetes. 2015;9(6):426\u201331.","journal-title":"Prim Care Diabetes"},{"issue":"7","key":"1141_CR17","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/dom.12606","volume":"18","author":"C Vatier","year":"2016","unstructured":"Vatier C, Fetita S, Boudou P, Tchankou C, Deville L, Riveline J, et al. One-year metreleptin improves insulin secretion in patients with diabetes linked to genetic lipodystrophic syndromes. Diabetes Obes Metab. 2016;18(7):693\u20137.","journal-title":"Diabetes Obes Metab"},{"issue":"21","key":"1141_CR18","first-page":"1044","volume":"30","author":"X Girerd","year":"2001","unstructured":"Girerd X, Hanon O, Anagnostopoulos K, Ciupek C, Mourad JJ, Consoli S. Assessment of antihypertensive compliance using a self-administered questionnaire: development and use in a hypertension clinic. Presse Med. 2001;30(21):1044\u20138.","journal-title":"Presse Med"},{"issue":"Suppl 1","key":"1141_CR19","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1111\/j.1524-4733.2005.00066.x","volume":"8","author":"MJ Atkinson","year":"2005","unstructured":"Atkinson MJ, Kumar R, Cappelleri JC, Hass SL. Hierarchical construct validity of the treatment satisfaction questionnaire for medication (TSQM version II) among outpatient pharmacy consumers. Value Health. 2005;8(Suppl 1):S9\u2013S24.","journal-title":"Value Health"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1141-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-019-1141-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1141-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T23:17:38Z","timestamp":1594423058000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-019-1141-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,12]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1141"],"URL":"https:\/\/doi.org\/10.1186\/s13023-019-1141-2","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,12]]},"assertion":[{"value":"19 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval and consent to participate: all patients gave their informed consent for metabolic investigations at baseline and after 1\u2009year of therapy, and for self-questionnaire used which were approved by the local ethics committee (Comit\u00e9 de Protection des Personnes, Paris-St-Louis).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors reviewed and approved the final article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"C Va has received personal fees for consultancy, travel, or accommodation from Aegerion Pharmaceuticals, Lilly, Novo Nordisk, Sanofi, Servier, and Vitalaire. MCV was invited by Aegerion for a conference (transportation and accommodation, with no other fee) as received non-financial support from Novartis and Ipsen and personal fees for lecture, travel, or accommodation by Sanofi and GSK. C Vi has received personal fees for consultancy, lecture, travel, or accommodation from Aegerion Pharmaceuticals, Air Products, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead, Jansen-Cilag, Merck-Serono, Novo Nordisk, Orkyn, Sanofi, Servier, Viiv-Healthcare, and Vitalaire, and institutional research grants from Pierre-Fabre M\u00e9dicament, Roche Diagnostics and Servier. JFG has received personal fees for consultancy, lecture, travel, or accommodation from AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Novartis, Novo Nordisk, Sanofi-Aventis and Servier. He has received research grants from Eli Lilly, Novo Nordisk and Sanofi. DK, AD, OL, IJ, MB have nothing to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"177"}}